Kiniksa Pharmaceuticals, Ltd. (NASDAQ:KNSA) Q1 2023 Earnings Call Transcript
Operator: Good day and thank you for standing by and welcome to the Kiniksa Pharmaceuticals First Quarter 2023 Earnings Conference Call.
Source: insidermonkey.com
Page 2 - Mark Ragosa News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Mark Ragosa. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Mark Ragosa Today - Breaking & Trending Today
Kiniksa Pharmaceuticals (KNSA) CEO Sanj Patel on Q4 2021 Results - Earnings Call Transcript
Kiniksa Pharmaceuticals (NASDAQ:KNSA) Q4 2021 Results Earnings Conference Call February 22, 2022, 08:30 AM ET Company Participants Rachel Frank - Associate Director, Investor Relations Sanj...
Source: seekingalpha.com
Kiniksa Reports First Quarter 2021 Financial Results and
(rilonacept) launched as the first and only FDA-approved therapy for recurrent pericarditis - - Mavrilimumab Phase 2 severe COVID-19 data demonstrated a reduction in mechanical ventilation and death at Day 29; Phase 3 enrollment ongoing - - Final KPL-404 Phase 1 data support further development in patients; Phase 2 proof-of-concept trial initiation planned for 2H 2021 - - Cash reserves of approximately $264 million - HAMILTON, Bermuda, May 04, 2021 (GLOBE NEWSWIRE) -- Kiniksa Pharmaceuticals, Ltd. (Nasdaq: KNSA) (“Kiniksa”), a biopharmaceutical company with a portfolio of assets design...
Source: globenewswire.com